Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Keymed Biosciences (2162 HK)
Watchlist
63
Analysis
Health Care
•
Hong Kong
Keymed Biosciences Inc. operates a biotechnology company. The Company focus on the in-house discovery and development of innovative biological therapies. Keymed Biosciences provides services in China.
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
28 Apr 2024 18:04
Voluntary Announcement Phase Iii Clinical Trial Of Stapokibart Injection For The Treatment Of Seasonal Allergic Rhinitis Achieved Primary Endpoints
Attachment
Exchange Announcement •
24 Apr 2024 16:37
Notification Letter To Non-Registered Shareholders And Reply Form - Arrangement Of Electronic Dissemination Of Corporate Communications
Attachment
Exchange Announcement •
24 Apr 2024 16:35
Notification Letter To Registered Shareholders And Reply Form - Arrangement Of Electronic Dissemination Of Corporate Communications
Attachment
Exchange Announcement •
24 Apr 2024 16:34
Form Of Proxy For Use At Annual General Meeting
Attachment
Exchange Announcement •
24 Apr 2024 16:33
Notice Of Annual General Meeting
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x